Profile photo Harry Heijerman

Harry Heijerman

Full Professor

Strategic program(s):


Harry Heijerman earned his MD (1984, cum laude) and his PhD in 1991 ("Studies in the clinical management of Cystic Fibrosis") He registered as pulmonologist in 1989, all above at the Leiden University Medical School. From 1996 till 2017 he was head of the department of Pulmonology at the Haga teaching Hospital in The Hague. Since 2017 he is head of the Department of Pulmonology and professor at the University Medical Center  Utrecht The Netherlands. During his whole career he focussed on optimization of treatment for people with Cystic Fibrosis. He was PI of multiple mono and multi center studies focusing on understanding and treating Cystic Fibrosis. In 2002 he was the founding editor of the "Journal of Cystic Fibrosis". At present he is involved in several clinical studies addressing CFTR function in Cystic Fibrosis with the aim to find a cure for this life long inheritable disease, This work is done in close collaboration with the department of Pediatric Pulmonology. 

Recent publications

Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy Pierre-Régis Burgel, Manfred Ballmann, Pavel Drevinek, Harry Heijerman, Andreas Jung, Jochen G Mainz, Daniel Peckham, Barry J Plant, Carsten Schwarz, Giovanni Taccetti, Alan Smyth
BMJ open respiratory research, 2024, vol. 11, p.1-9
Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease Bente L. Aalbers, Firdaus A.A. Mohamed Hoesein, Regina W. Hofland, Inez Bronsveld, Marian A. Kruijswijk, Suzan Schotman, Corlien W. Slingerland, Hannah Panhuis, C. Kors van der Ent, Harry G.M. Heijerman
Pediatric Pulmonology, 2023, vol. 58, p.2317-2322
The effect of azithromycin on sputum inflammatory markers in bronchiectasis L C Terpstra, J Altenburg, H J Doodeman, Y S Sabogal Piñeros, R Lutter, H G M Heijerman, W G Boersma
BMC Pulmonary Medicine, 2023, vol. 23
Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE) Danya Muilwijk, Tessa J. van Paridon, Doris C. van der Heijden, Brenda M. Faber-Bisschop, Domenique D. Zomer-van Ommen, Harry G.M. Heijerman, Cornelis K. van der Ent
EClinicalMedicine, 2023, vol. 62
Treatment with inhaled antibiotics in bronchiectasis, side effects, and evaluation of the tolerance test; analysis from the BATTLE randomized controlled trial Lotte C Terpstra, Daphne van der Geest, Inez Bronsveld, Harry Heijerman, Wim G Boersma
The clinical respiratory journal, 2023, vol. 17, p.748-753
The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort Lisa M Oppelaar, Bart Luijk, Harry G M Heijerman, Harold W De Valk, Gerdien Belle- van Meerkerk
Clinics (São Paulo, Brazil), 2023, vol. 78

Fellowships & Awards

2017: Officier in de orde van Oranje Nassau

External positions

Member Advisory Board, Vertex incorporated

Chairman medical advisory board Dutch CF Foundation, Dutch Cystic Fibrosis Foundation (NCFS)